News

Business Insider5y
Oyster Point Pharma Announces Positive Top-Line Results From the Phase 1 “ZEN” Study of Its Lead Nicotinic Agonist Nasal Spray in Development for the ... - Markets Insider
PRINCETON, N.J., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ...
Nasdaq3y
ZEN Graphene Solutions Announces Name Change to Zentek Ltd
GUELPH, ON/ ACCESSWIRE/ October 27, 2021/ ZEN Graphene Solutions Ltd., ... and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Nasdaq5y
Oyster Point Pharma Announces Positive Top-Line Results From the Phase 1 “ZEN” Study of Its Lead Nicotinic Agonist Nasal Spray in Development for the Treatment of Dry Eye ...
PRINCETON, N.J., Nov. 22, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization ...